IDEAYA Biosciences Inc at Citi BioPharma Conference (Virtual) Transcript
Okay, great. All right. Sorry about that. So again, I'm Yigal Nochomovitz. I'm one of the biotech analysts at Citi. And I'm here with Joel Beatty, my colleague, who also covers biotech. And I believe Mohit should be joining -- Mohit Bansal should be joining us soon.
As a reminder, if you have questions, you can e-mail me or you can e-mail Joel or Mohit. You can also submit a question via the showcase feature on the open exchange interface. So today, we're going to be talking about targeted therapy for oncology. So a great topic. And I'm very pleased to have with me four distinguished members of management. From Calithera, Susan Molineaux, the CEO, from IDEAYA, Yujiro Hata, also a CEO, Jacob Chacko from ORIC, another CEO, and finally, Briggs Morrison, CEO of Syndax. So welcome everyone to the panel and hope for a good discussion.
Questions & Answers
So maybe we'll start with some general questions, and then we can move into some of the more
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
